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2269e72.Elevated Galectin-10 Expression of
IL-22-Producing T Cells in Patients
with Atopic Dermatitis
Journal of Investigative Dermatology (2016) 136, 328e331; doi:10.1038/JID.2015.369TO THE EDITOR
Atopic dermatitis (AD) is a highly pru-
ritic, chronic, relapsing skin disease
characterized by typically distributed
skin lesions. Recently, subsets of T cells
including TH1, TH2, TH17, TH22, and
regulatory T (Treg) cells have been
implicated as contributing factors to the
immune dysregulation of AD. In this
study, by using different quantitative
proteomics, we identified differentially
expressed proteins in CD3þ T cells
from patients with AD and healthy
controls (HCs), and found that galectin-
10 was elevated in IL-22-producing
CD4þ T cells in patients with AD.
This study was approved by the
institutional review board, and written
informed consent was obtained from
each patient. A total of 45 patients
with AD and 20 HCs were enrolled
in this study. Diagnosis of AD was
made according to the criteria of
Hanifin and Rajka (1980). Patients
were classified based on their allergic
history, skin prick test, ImmunoCAP
test, and serum IgE (Supplementary
Table S1 online). Detailed methods
were described in the Supplementary
Methods online.To study the differential protein
expression from CD3þ T cells in HCs
and patients with AD, we performed
LC/MS/MS analysis. Quantitative
analysis based on the normalized
spectral index (SIN) of identified pro-
teins (Griffin et al., 2010) resulted in
Supplementary Table S2 online. Among
the total 636 proteins identified, 75 and
81 showed higher expressions of five
times more in CD3þ T cells in patients
with AD and in HCs, respectively.
Extracted ion chromatograms of pep-
tides from galectin-10 and S100A9
increased in patients with AD
(Figure 1a) were presented with their
MS/MS spectra (Supplementary
Figure S1 online), confirmed by west-
ern blot analysis to be highly expressed
in patients with AD (Figure 1b).
Confocal laser microscopy also showed
higher intensities of galectin-10 staining
in CD3þ T cells from patients with AD
compared with HCs (Figure 1c).
As the upregulation of galectin-10
was mainly attributed to CD4þ T cells
(Figure 2a), we performed flow cytom-
etry using CD3þCD4þ T cells in the
following analysis. Galectin-10 was
significantly upregulated in IL-22expressing CD3þCD4þ T cells from
patients with AD compared with HCs
(Figure 2b). There was no significant
difference of galectin-10 expression in
CD3þCD4þ T cells producing other
cytokines such as IL-17, IFN-g, IL-4, or
IL-10 (Figure 2b and Supplementary
Figure S2 online). In the immunohisto-
chemical staining, galectin-10 was
highly expressed in CD3þ T cells in AD
skin, whereas its expression was nearly
undetectable in the normal skin
(Figure 2c). Interestingly, significant
acanthosis was also observed adjacent
to the dermal area where galectin-10þ
CD3þ T cells were present, implying
that epidermal hyperplasia in AD may
result from galectin-10þ T cells pro-
ducing IL-22.
Next, we performed a correlation
study between serum galectin-10 and
various clinical and laboratory vari-
ables (Noh et al., 2014). The serum
galectin-10 were significantly higher
in patients with AD compared with
HCs (Figure 2d, and Supplementary
Table S3 online) showing a positive
correlation between galectin-10 levels
and eczema area and severity index
score (r ¼ 0.409, P ¼ 0.018), and
investigator’s global assessment
(r ¼ 0.553, P ¼ 0.001). No significant
correlation was observed between
serum galectin-10 and cell counts,
Figure 1. Proteomic analysis and western blot analysis of CD3D T cells from patients with AD and HCs. (a) Extracted ion chromatograms representing that
peptides from galectin-10 and S100A9 were increased in T cells of patients with AD vs. HCs. (b) Western blot analysis of identified proteins in CD3þ T cells from
patients with AD and HCs. (c) Confocal laser microscopy of purified CD3þ T cells stained with anti-galectin-10 (green) and DAPI (blue). Data shown are
representative of three independent experiments. Scale bar ¼10 mm. **P < 0.01. AD, atopic dermatitis; DAPI, 40,6-diamidino-2-phenylindole; HCs, healthy
controls.
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vitamin D, or eczema area. There was
no significant difference of galectin-10
between extrinsic AD and intrinsic AD
(data not shown).
In this study, we first performed
large-scale analyses such as the
normalized spectral index (SIN) to
identify differentially expressed pro-
teins. As a local approach, we used
extracted ion chromatography that
determines abundance of specific
target peptide converted from mass
spectrometry-derived peptide data
(Zybailov et al., 2005) to minimize
errors caused by large-scale prote-
omics. Among S100A9 and galectin-
10, galectin-10 was chosen for further
analyses, as galectin-10 was recently
shown to be associated with allergic
diseases such as asthma.
Galectins, a family of animal
lectins that bind N-acetyllactosamine-
containing glycans deciphering thebiological information of glycosylation
signature, are known to have multiple
roles in innate and adaptive immunity.
For example, deletion of galectin-1
enhanced antigen-specific TH1 and
TH17 responses and autoimmune
inflammation (Blois et al., 2007;
Toscano et al., 2007), whereas dele-
tion of galectin-3 decreased pathogenic
TH1 and TH17 responses reducing
neuroinflammation (Jiang et al., 2009).
Among galectin family members,
galectin-10 was initially described
exclusively in eosinophils and baso-
phils (Ackerman et al., 1982, 1993;
Archer and Blackwood, 1965). How-
ever, CRTH2þCD4þ TH2 memory cells
were reported to undergo further TH2
polarization and upregulated galectin-
10, when activated by thymic stromal
lymphopoietin-activated dendritic
cells (Wang et al., 2006). Recently,
mRNA of galectin-10 was reported to
be overexpressed in the peripheralblood of patients with aspirin-induced
asthma compared with aspirin-
tolerant asthma (Devouassoux et al.,
2008). Galectin-10 was reported to
be expressed by human CD25þ Treg
cells and essential for their suppressive
function (Kubach et al., 2007). In our
study, galectin-10 was significantly
increased in IL-22-producing T cells
from peripheral blood and lesional
skin of patients with AD compared
with HCs. As we performed intracel-
lular staining for flow cytometry
without any activation, patients with
AD present circulating activated T
cells producing IL-22. As IL-22 causes
epidermal hyperplasia, galectin-10
can be closely associated with
epidermal acanthosis that is a hallmark
of chronic AD lesion (Figure 2c).
CD3þ galectin-10þ T cells from
HCs showed the expression pattern
of central memory T (TCM, CD45-
ROþCCR7þCD62Lþ), not the patternswww.jidonline.org 329
Figure 2. Increased expression of galectin-10 in IL-22-producing T cells, lesional skin, and sera of patients with AD. (a) Galectin-10 expression in CD3þCD4þ
T cells and CD3þCD8þ T cells; the increase of galectin-10 in AD was mainly attributed to CD3þCD4þ T cells. (b) The expression of galectin-10 was
significantly increased in IL-22-producing CD3þCD4þ T cells from patients with AD compared with HCs, whereas its expression was not significant in IL-17-
producing CD3þCD4þ T cells. Data shown are representative of three independent experiments. (c) Galectin-10 expression in the skin of HCs and patients
with AD. The superficial perivascular infiltrated CD3þ T cells in AD were strongly stained with galectin-10 marked by an arrow with a straight line. Arrows with
a dashed line indicate epidermal acanthosis adjacent to infiltrated CD3þ galectin-10þ T cells. Scale bars denotes for 100 mm (200) and 50 mm (400),
respectively. (d) Serum levels of galectin-10 were increased in the moderate and severe patients with AD. *P < 0.05; **P < 0.01. AD, atopic dermatitis; HCs,
healthy controls.
S Noh et al.
Galectin-10 Expression in Atopic Dermatitis
330of naive or effector memory T (TEM)
cells (Supplementary Figure S3 online).
As TCM have skin homing properties,
further experiments are required to
study galectin-10þ CD3þ T cells in
lesional skin (Clark et al., 2012).
The observations that the serum level
of galectin-10 was increased in patients
with AD compared with HCs and that
these levels correlate positively with
AD severity offer the possibility of
galectin-10 as a disease biomarker.
The origin of serum galectin-10 was
not determined in this study. The
observation that there is no significant
correlation between eosinophil, eosin-
ophil cationic protein, basophil, and
lymphocyte count and serum galectin-
10 level indicates that serum galectin-
10 might be directly correlated with aJournal of Investigative Dermatology (2016), Volumcertain subtype of T cells like TH22
cells.
In summary, using proteomic anal-
ysis, we identified galectin-10 to be
overexpressed in circulating CD3þ T
cells from patients with AD and in
chronic AD skin compared with HCs.
Increased expression of galectin-10 was
also observed in IL-22-producing CD4þ
T cells from patients with AD. Serum
levels of galectin-10 were higher in
patients with AD relative to HCs, and
this level correlated positively with AD
severity. A further study of galectin-10þ
T cells in chronic AD is warranted to
elucidate the clear role of galectin-10
in the pathogenesis of AD, and large-
scale studies could reveal the possibil-
ity of galectin-10 as a disease
biomarker for AD.e 136CONFLICT OF INTEREST
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2005;77:6218e24.Sub6 (Tri r 2), an Onychomycosis Marker
Revealed by Proteomics Analysis of
Trichophyton rubrum Secreted Proteins in
Patient Nail Samples
Journal of Investigative Dermatology (2016) 136, 331e333; doi:10.1038/JID.2015.367TO THE EDITOR
Onychomycosis, the most prevalent
nail disease, is mainly caused by two
dermatophyte species, Trichophyton
rubrum and Trichophyton interdigitale,
with a frequency in the range of 80%and
20%, respectively (Monod et al., 2002).
To determine if the proteases secreted by
T. rubrum in vitro during keratin diges-
tion were involved in nail degradation,
we investigated the fungus secretome in
onychomycosis by proteomics analysis.
In a first experiment, mass spec-
trometry analyses were performed us-
ing a pool of extracts from 12 donors
infected by T. rubrum as described
in the Supplementary Materials and
Methods online. Patient consent for
experiments was not required because
French laws consider human tissue
leftover from surgery as discarded ma-
terial. Proteins were extracted fromeach sample using a nonionic acid
labile surfactant (ALS-400). The secre-
tion of the following four secreted pro-
teases of T. rubrum proteins extracted
from nail beds was identified after
subsequent SDS-PAGE separation and
in-gel digestion coupled to mass spec-
trometry analysis: subtilisin-like prote-
ase 6 (Sub6, Q9UW97), subtilisin-like
protease 7 (Sub7, Q8NID9), dipeptidyl-
peptidase 5 (DppV, Q9UW98), and
leucine aminopeptidase 2 (Lap2,
Q5QHG6) (Table 1 and Supplementary
Table S1 online). In particular, 12
unique peptides were found for Sub6,
suggesting that this protease was
abundantly secreted during nail infec-
tion. No T. rubrum proteins were
detected in the collected samples from
abnormal nails with trauma but without
fungal infection (data not shown). No
additional proteins were identified froma sequential second extract, suggesting
that all soluble secreted proteins were
already extracted in the first extraction
(Supplementary Materials online). The
high amount of Sub6 secreted by
T. rubrum in onychomycosis and the
presence of DppV were confirmed by
Western blot analysis and by a shotgun
protein identification experiment in SDS-
PAGE gels using the same pooled extract
for mass spectrometry analysis and spe-
cific antisera (Supplementary Table S2
and Figure S1 online). Surprisingly, most
proteases secreted by the fungus during
its in vitro growth in a keratin medium
including subtilisin-like protease 3 (Sub3,
B8XGQ6), subtilisin-like protease 4
(Sub4, A7UKV6), leucine aminopepti-
dase 1 (Lap1, Q5QHG5), dipeptidyl
peptidase 4 (DppIV, Q5J6J3), and metal-
locarboxypeptidase (M14A, A6XGK3)
(Giddey et al., 2007; Zaugg et al., 2008)
were not detected either by mass spec-
trometry or by Western blot analysis
(Supplementary Table S3 and Figure S1
online).www.jidonline.org 331
